Search Results - "Santis, C. De"

Refine Results
  1. 1

    Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation by Dotoli, G M, De Santis, G C, Orellana, M D, de Lima Prata, K, Caruso, S R, Fernandes, T R, Rensi Colturato, V A, Kondo, A T, Hamerschlak, N, Simões, B P, Covas, D T

    Published in Bone marrow transplantation (Basingstoke) (01-06-2017)
    “…Acute GvHD (aGvHD) is a life-threatening complication of hematopoietic stem cell transplantation. Frontline therapy for aGvHD consists of corticosteroid…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    High-Dose Convalescent Plasma for Treatment of Severe COVID-19 by Focosi, Daniele, Casadevall, Arturo

    Published in Emerging infectious diseases (01-05-2022)
    “…In summary, our study emphasizes that CCP should not be transfused late in the course of disease, when the clinical course is driven by inflammation. Google…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    The hypothalamic–pituitary–adrenal and -thyroid axes activation lasting one year after an earthquake swarm: results from a big data analysis by Spaggiari, G., Setti, M., Tagliavini, S., Roli, L., De Santis, M. C., Trenti, T., Rochira, V., Santi, D.

    Published in Journal of endocrinological investigation (01-07-2021)
    “…Purpose To cope physical and/or psychological threats, the human body activates multiple processes, mediated by a close interconnection among brain, endocrine…”
    Get full text
    Journal Article
  9. 9

    Treatment of Horizontal Canal Benign Paroxysmal Positional Vertigo : A New Rehabilitation Technique by De Santis, C., Testa, D., Motta, G., Trusio, A., Castaldo, G.

    Published in TheScientificWorld (01-01-2012)
    “…The aim of this study was to evaluate the effectiveness of a new technical variant applied to the Gufoni's manoeuvre, in the treatment of horizontal canal…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Mammographic density to predict response to neoadjuvant systemic breast cancer therapy by Di Cosimo, S., Depretto, C., Miceli, R., Baili, P., Ljevar, S., Sant, M., Cappelletti, V., Folli, S., Gennaro, M., De Braud, F. G., Bianchi, G., Vingiani, A., Pruneri, G., Marchianò, A., La Rocca, E., De Santis, M. C., Scaperrotta, G. P.

    “…Background Mammographic density (MD) is a risk factor for breast cancer (BC) development, and recurrence. However, its predictive value has been less studied…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20